Literature DB >> 16006099

Hepatic expression of toll-like receptor 4 in primary biliary cirrhosis.

Ai-Ping Wang1, Kiyoshi Migita, Masahiro Ito, Yasushi Takii, Manabu Daikoku, Terufumi Yokoyama, Atsumasa Komori, Minoru Nakamura, Hiroshi Yatsuhashi, Hiromi Ishibashi.   

Abstract

Toll-like receptor 4 (TLR4) is a receptor for bacterial lipopolysaccharide, which is suggested to be involved in the pathogenesis of disease of hepatobiliary tracts. To explore a possible role for this receptor in primary biliary cirrhosis (PBC), we investigated the expression of TLR4 in liver tissues from PBC patients. We studied liver biopsy sections from 62 PBC patients and 41 patients with chronic hepatitis C (CHC). Expression of TLR4 in paraffin-embedded sections was analyzed by immunohistochemistry. The bile duct epithelial cells (BECs) of PBC liver tissues markedly expressed TLR4, whereas BECs of CHC liver tissues barely expressed TLR4. The TLR4 expression was also observed in periportal hepatocytes of PBC liver tissues and its expression was extended to interlobular hepatocytes in advanced stage PBC. Although periportal hepatocytes of CHC liver tissues expressed TLR4, its expression levels were not correlated with the fibrosis stage. Our data demonstrated that TLR4 was expressed in BECs and periportal hepatocytes in PBC livers, suggesting the possible involvement of bacterial pathogens and TLR4 in the inflammatory processes of PBC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16006099     DOI: 10.1016/j.jaut.2005.05.003

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  35 in total

1.  Involvement of commensal bacteria may lead to dysregulated inflammatory and autoimmune responses in a mouse model for chronic nonsuppurative destructive cholangitis.

Authors:  Ikuko Haruta; Ken Kikuchi; Minoru Nakamura; Katsuhiko Hirota; Hidehito Kato; Hiroshi Miyakawa; Noriyuki Shibata; Yoichiro Miyake; Etsuko Hashimoto; Keiko Shiratori; Junji Yagi
Journal:  J Clin Immunol       Date:  2012-06-03       Impact factor: 8.317

2.  The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases.

Authors:  João-Bruno Soares; Pedro Pimentel-Nunes; Roberto Roncon-Albuquerque; Adelino Leite-Moreira
Journal:  Hepatol Int       Date:  2010-10-21       Impact factor: 6.047

Review 3.  The immunobiology of cholangiocytes.

Authors:  Xian-Ming Chen; Steven P O'Hara; Nicholas F LaRusso
Journal:  Immunol Cell Biol       Date:  2008-05-27       Impact factor: 5.126

4.  Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice.

Authors:  Guo-Xiang Yang; Zhe-Xiong Lian; Ya-Hui Chuang; Yuki Moritoki; Ruth Y Lan; Kanji Wakabayashi; Aftab A Ansari; Richard A Flavell; William M Ridgway; Ross L Coppel; Koichi Tsuneyama; Ian R Mackay; M Eric Gershwin
Journal:  Hepatology       Date:  2008-06       Impact factor: 17.425

5.  Etiopathogenesis of primary biliary cirrhosis: an overview of recent developments.

Authors:  Palak J Trivedi; Sue Cullen
Journal:  Hepatol Int       Date:  2012-03-20       Impact factor: 6.047

6.  Bidirectional Cross-Talk between Biliary Epithelium and Th17 Cells Promotes Local Th17 Expansion and Bile Duct Proliferation in Biliary Liver Diseases.

Authors:  Hannah C Jeffery; Stuart Hunter; Elizabeth H Humphreys; Ricky Bhogal; Rebecca E Wawman; Jane Birtwistle; Muhammad Atif; Christopher J Bagnal; Giovanny Rodriguez Blanco; Naomi Richardson; Suz Warner; Warwick B Dunn; Simon C Afford; David H Adams; Ye Htun Oo
Journal:  J Immunol       Date:  2019-08-07       Impact factor: 5.422

Review 7.  Advances in cholangiocyte immunobiology.

Authors:  Gaurav Syal; Michel Fausther; Jonathan A Dranoff
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-09-06       Impact factor: 4.052

Review 8.  Therapeutic targets for cholestatic liver injury.

Authors:  Benjamin L Woolbright; Hartmut Jaeschke
Journal:  Expert Opin Ther Targets       Date:  2015-10-19       Impact factor: 6.902

Review 9.  Role of autoimmunity in primary biliary cirrhosis.

Authors:  Tian-Yan Shi; Feng-Chun Zhang
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

10.  Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis.

Authors:  Jinsheng Guo; Scott L Friedman
Journal:  Fibrogenesis Tissue Repair       Date:  2010-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.